SIETES :: 91969 citas

Resultados de la búsqueda por BENFLUOREX REFINAR BÚSQUEDA

1.

Coste J. Diverging approaches of pharmacovigilance and pharmacoepidemiology to assessing drug safety: epistemological and ethical implications. Pharmacoepidemiol Drug Saf 2017;26:600-2. [Ref.ID 101606]

2.

Anónimo. Paris prosecutor indicts drugmaker Servier, french drug regulator over benfluorex scandal. DIA Daily 2017:1. [Ref.ID 101599]

3.

Anónimo. Médicaments de l'obésité: trop de dégâts trop longtemps. Prescrire 2017;37:105. [Ref.ID 101442]

4.

Anónimo. Benfluorex: un bilan 1976-2015. Prescrire 2016;36:755. [Ref.ID 100895]

5.

Casassus B. Drug scandals in France: have the lessons been learnt?. Lancet 2016;388:550-2. [Ref.ID 100574]

6.

Stafford N. Jacques Servier. BMJ 2014;348:g3298. [Ref.ID 98043]

7.

Anónimo. Comportements violents envers autrui sous l'effet de médicaments. Prescrire 2014;34:110-3. [Ref.ID 97126]

8.

Anónimo. Valvulopathies d'origine médicamenteuse. Prescrire 2013;33:668-72. [Ref.ID 96188]

9.

Mullard A. Mediator scandal engulfs French compensation body. Lancet 2013;381:1803. [Ref.ID 95500]

10.

Deltour N, Coste M, Tupinon-Mathieu I. Letter to the editor. Pharmacoepidemiol Drug Saf 2012;21:584-5. [Ref.ID 93070]

11.

Anónimo. Recherche clinique sous influence: penser les alternatives. Prescrire 2012;32:311-4. [Ref.ID 92580]

12.

Fournier A, Zureik M. Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France. Pharmacoepidemiol Drug Saf 2012;21:343-51. [Ref.ID 92514]

13.

Benkimoun P. Appetite suppressant was probably responsible for 1300 deaths, study shows. BMJ 2012;344:e996. [Ref.ID 92377]

14.

Anónimo. Anfetaminas en España. Boletín de la Tarjeta Amarilla (Centro de Farmacovigilancia de Castilla y León) 2011:2. [Ref.ID 91964]

15.

Kmietowicz Z. Fraud agency investigates conflicts of interest inside European drug regulator. BMJ 2011;343:967. [Ref.ID 91817]

16.

Braillon A. Mediator: who's to blame?. Lancet 2011;377:2003-4. [Ref.ID 91302]

17.

Vincent L, Guardiola B, Tsouderos Y, Canet E. Mediator: who's to blame?. Lancet 2011;377:2003. [Ref.ID 91301]

18.

Waller P, Evans S. Mediator: who's to blame?. Lancet 2011;377:2022-03. [Ref.ID 91300]

19.

Arie S. France is set to radically overhaul its drug regulatory system. BMJ 2011;343:d4979. [Ref.ID 91256]

20.

Anónimo. Médicaments: priorité à l'intérêt des patients et à la santé publique. Prescrire 2011;31:304-6. [Ref.ID 90398]